Fortress Biotech, Inc. (FBIOP)
USD 6.37
(-7.41%)
USD 6.37
(-7.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 84.51 Million | 75.74 Million | 68.79 Million | 45.59 Million | 36.62 Million | 26.88 Million |
| Cost of Revenue | 26.66 Million | 30.77 Million | 32.08 Million | 14.59 Million | 10.53 Million | 6.12 Million |
| Gross Profit | 57.85 Million | 44.96 Million | 36.7 Million | 31 Million | 26.09 Million | 20.75 Million |
| Operating Expenses | 200.19 Million | 247.22 Million | 215.7 Million | 125.27 Million | 136.91 Million | 140.75 Million |
| Selling, General and Administrative Expenses | 94.12 Million | 113.65 Million | 86.84 Million | 61.16 Million | 55.59 Million | 53.37 Million |
| Research and Development Expenses | 106.07 Million | 134.87 Million | 128.86 Million | 64.1 Million | 81.32 Million | 87.38 Million |
| Other Expenses | - | -1.3 Million | 25.16 Million | 2.83 Million | 6.09 Million | 68 Thousand |
| Cost and Expenses | 226.85 Million | 278 Million | 247.79 Million | 139.86 Million | 147.44 Million | 146.87 Million |
| Operating Income | -142.34 Million | -202.26 Million | -179 Million | -94.27 Million | -110.81 Million | -119.99 Million |
| Interest Expense | 11.91 Million | 13.64 Million | 15.3 Million | 9.7 Million | 11.84 Million | 10.34 Million |
| Income Tax Expense | 521 Thousand | 449 Thousand | 473 Thousand | 136 Thousand | -49.85 Million | -463 Thousand |
| Earnings before Tax | -153.63 Million | -213.46 Million | -164.35 Million | -102.84 Million | -101.66 Million | -130.8 Million |
| Net Income | -60.63 Million | -213.91 Million | -164.82 Million | -102.98 Million | -51.8 Million | -84.14 Million |
| Earnings Per Share Basic | -8.47 | -36.10 | -30.26 | -21.45 | -14.20 | -29.04 |
| Earnings Per Share Diluted | -8.47 | -36.10 | -30.26 | -21.45 | -14.20 | -29.04 |
| Weighted Average Shares Outstanding | 8.11 Million | 5.92 Million | 5.44 Million | 4.8 Million | 3.64 Million | 2.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.11 Million | 5.92 Million | 5.44 Million | 4.8 Million | 3.64 Million | 2.89 Million |
| Gross Margin | 0.68 | 0.59 | 0.53 | 0.68 | 0.71 | 0.77 |
| EBIT Margin | -1.58 | -2.65 | -2.59 | -2.04 | -2.83 | -4.34 |
| Profit Margin | -0.72 | -2.82 | -2.40 | -2.26 | -1.41 | -3.13 |
| EBITDA | -133.64 Million | -190.46 Million | -142.25 Million | -87.82 Million | -85.15 Million | -118.4 Million |
| Earnings Before Tax Margin | -1.68 | -2.67 | -2.60 | -2.07 | -3.03 | -4.46 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.85 Million | 13.03 Million | 19.94 Million | 84.51 Million | 34.75 Million | 17.38 Million |
| Cost of Revenue | 6.54 Million | 6.81 Million | 6.39 Million | 28.89 Million | 6.42 Million | 7.76 Million |
| Gross Profit | 8.31 Million | 6.21 Million | 13.55 Million | 55.62 Million | 28.32 Million | 9.61 Million |
| Operating Expenses | 36.14 Million | 42.78 Million | 33.21 Million | 194.86 Million | 42.08 Million | 56.58 Million |
| Selling, General and Administrative Expenses | 20.82 Million | 17.94 Million | 19.13 Million | - | 21.73 Million | 24.43 Million |
| Research and Development Expenses | 12.67 Million | 24.83 Million | 14.07 Million | - | 20.34 Million | 32.14 Million |
| Other Expenses | 2.64 Million | -21 Thousand | -1.35 Million | -3.4 Million | 620 Thousand | 395 Thousand |
| Cost and Expenses | 42.68 Million | 49.59 Million | 39.6 Million | 223.75 Million | 48.51 Million | 64.34 Million |
| Operating Income | -27.78 Million | -36.56 Million | -19.65 Million | -139.24 Million | -13.75 Million | -50.1 Million |
| Interest Expense | -2.12 Million | -2.6 Million | 1.51 Million | 11.91 Million | 1.87 Million | 5.2 Million |
| Income Tax Expense | -2.56 Million | -1.71 Million | 379 Thousand | 521 Thousand | 141 Thousand | -28.92 Million |
| Earnings before Tax | -13.33 Million | -17.73 Million | -28.6 Million | -153.63 Million | -10.58 Million | -59.3 Million |
| Net Income | -13.33 Million | -17.73 Million | -9.27 Million | -60.63 Million | -5.04 Million | -24.77 Million |
| Earnings Per Share Basic | -0.73 | -1.03 | -0.86 | - | -0.67 | -3.36 |
| Earnings Per Share Diluted | -0.73 | -1.03 | -0.86 | - | -0.67 | -3.36 |
| Weighted Average Shares Outstanding | 18.31 Million | 17.15 Million | 10.75 Million | 8.11 Million | 7.49 Million | 7.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.31 Million | 17.15 Million | 10.75 Million | 8.11 Million | 7.49 Million | 7.37 Million |
| Gross Margin | 0.56 | 0.48 | 0.68 | 0.66 | 0.82 | 0.55 |
| EBIT Margin | -1.87 | -2.81 | -0.90 | - | -0.30 | -2.64 |
| Profit Margin | -0.90 | -1.36 | -0.47 | -0.72 | -0.15 | -1.43 |
| EBITDA | -27.78 Million | -36.56 Million | -17.94 Million | - | -10.49 Million | -45.89 Million |
| Earnings Before Tax Margin | -1.87 | -2.81 | -0.99 | -1.65 | -0.40 | -2.88 |
603507
ONGC
VSVS
DSSA
ANDE
WELCORP